Nevirapine toxicity--implications for management of South African patients.
Wood
Robin
R
The Desmond Tutu HIV Centre, Institute of Infectious Disease and Molecular Medicine, University of Cape Town. robin.wood@hiv-research.org.za
D019380:Anti-HIV Agents / Q000009:adverse effects*; D002986:Clinical Trials as Topic; D005260:Female; D015658:HIV Infections / Q000188:drug therapy* / Q000517:prevention & control / Q000635:transmission; D015497:HIV-1 / Q000187:drug effects; D006801:Humans; D018445:Infectious Disease Transmission, Vertical / Q000517:prevention & control*; D019829:Nevirapine / Q000009:adverse effects*; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy* / Q000517:prevention & control; D013019:South Africa; D016896:Treatment Outcome
D019380:Anti-HIV Agents; D019829:Nevirapine